Orlando, FL3 Active Studies

IgA Nephropathy Clinical Trials in Orlando, FL

Find 3 actively recruiting iga nephropathy clinical trials in Orlando, FL. Connect with local research sites and explore new treatment options.

3
Active Trials
3
Sponsors
861
Enrolling

Recruiting IgA Nephropathy Studies in Orlando

About IgA Nephropathy Clinical Trials in Orlando

IgA nephropathy is the most common form of glomerulonephritis worldwide, caused by deposits of immunoglobulin A in the kidneys. It can lead to kidney inflammation and progressive kidney damage. Treatment includes blood pressure management, immunosuppression, and newer targeted therapies.

There are currently 3 iga nephropathy clinical trials recruiting participants in Orlando, FL. These studies are seeking a combined 861 participants. Research is being sponsored by Biogen, Takeda, Calliditas Therapeutics AB. Clinical trial participation is free and participants receive study-related medical care at no cost.

IgA Nephropathy Clinical Trials in Orlando — FAQ

Are there iga nephropathy clinical trials in Orlando?

Yes, there are 3 iga nephropathy clinical trials currently recruiting in Orlando, FL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Orlando?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Orlando research site will contact you about next steps.

Are clinical trials in Orlando free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Orlando studies also compensate for your time and travel.

What iga nephropathy treatments are being tested?

The 3 active trials in Orlando are testing new therapies including novel drugs, biologics, and treatment approaches for iga nephropathy.

Data updated March 2, 2026 from ClinicalTrials.gov